-
Issue 31/2013 - Biotechnology Service Center is FDA certified
Time of Update: 2022-11-12
(Wang Ruizhi) The Biotechnology Service Center is FDA certifiedRecently, Shijiazhuang Runbai Pharmaceutical Technology Co.
(Wang Ruizhi) The Biotechnology Service Center is FDA certifiedRecently, Shijiazhuang Runbai Pharmaceutical Technology Co.
(Wang Ruizhi) The Biotechnology Service Center is FDA certifiedRecently, Shijiazhuang Runbai Pharmaceutical Technology Co.
-
Shandong, Shanxi and other places have clarified the implementation time of the seventh batch of national centralized procurement of drugs
Time of Update: 2022-11-04
For example, Shandong Province clarified in the notice the "timetable" for the landing of the results of the seventh batch of national centralized procurement drugs: before November 13, 2022, the main supplier enterprises and the backup supply enterprises will respectively hang the selected drugs and spare drugs on the provincial centralized procurement platform for drugs and equipment according to the selected price, so that medical institutions can purchase an appropriate amount of selected drugs for stocking.
-
BIFT-CGT 2022 Biopharmaceutical Innovation and Frontier Technology Summit ended successfully
Time of Update: 2022-11-04
A successful conclusion | BIFT-CGT 2022 China Biopharmaceutical Innovation and Frontier Technology Summit & Cell and Gene Therapy Innovation Conference BIFT-CGT 2022 China Biopharmaceutical Innovatio
-
good news
Time of Update: 2022-04-15
[Pharmaceutical Network Industry News] Recently, Hainan Boao Lecheng International Medical Tourism Pilot Zone has successfully introduced the invasive fungal disease treatment drug-AmBisome (Amphotericin B liposome for injection), which will provide domestic invasive fungal diseases.
-
Ten billion cold Chinese patent medicine market TOP20 2 billion major varieties lead
Time of Update: 2021-12-05
As the best-selling category in the retail market, the terminal sales of cold Chinese patent medicines in physical pharmacies in Chinese cities have exceeded 10 billion yuan, and China Resources Sanjiu Pharmaceutical has continued to rank as the top seller .
-
Baili Pharmaceutical's EGFR/HER3 double antibody was approved for two clinical trials
Time of Update: 2021-11-05
Text|Pharmaceutical Mission HillsThe latest announcement by the Center for Drug Evaluation (CDE) of the State Food and Drug Administration of China shows that the Class 1 new drug SI-B001 bispecific a
-
Junshi Biological released the first-line Phase III study data of Teriprizumab in the World Lung Cancer Conference (WCLC) for the first-line treatment of non-small cell lung cancer
Time of Update: 2021-09-19
08) for the first phase III key registration of teriprizumab combined with chemotherapy for first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) Interim analysis results of the clinical study (CHOICE-01 study) .
-
How "Pharmaceutical Headlines" Multinational Pharmaceutical Companies Play the Internet Plus
Time of Update: 2021-01-19
Novarma, Pfizer, Lilly high-profile into the market to see how pharmaceutical companies play the "Internet plus" China's Internet plus medicine high-gloss moment is coming.
The American Chemical Society(ACS) website has released a list of 10 high-profile start-ups for 2020.
headlines: how start-ups are using chemical innovation for the benefit of humanity.
-
Because the packaging is confused with each other! Both injections were recalled
Time of Update: 2020-11-17
Company Announcement Date: August 28, 2020 FDA Release Date: August 31, 2020 Product Category: Drug Recall Reason: Product Confusion (Sillin bottles may be packaged in the wrong small box) Product Description: Injection methylacycline and hydrochloride iodide Mylan said its MYlan Institutional LLC subsidiary in the United States is voluntarily recalling four batches of injection products nationwide.
-
Pharmaceutical province 40 varieties to carry out the volume of procurement
Time of Update: 2020-10-24
This means that injections, especially drugs with narrow treatment windows, should pay more attention to safety and effectiveness, with rich medical resources and procurement volume of Shandong Province, will be divided into two evaluation groups, high quality and low price are selected, or take this into account.
-
Three Class 1 new drugs were approved clinically from Haihe Pharmaceuticals, Lijin Biological, and Lingke Pharmaceuticals
Time of Update: 2020-10-17
1, Sea and Drugs: CYH33 Mechanism of Action/Target: PI3K alpha This approved clinical adaptation: PI3K signaling path paths in specific solid tumor patients play an important role in regulating cell growth, movement, survival, metabolism, and angiogenesy.
-
Drugstores are aware that a strict investigation of such drugs has begun
Time of Update: 2020-10-13
Generally speaking, check the second category of psycho-drugs mainly check the purchase and sale channels, buyer qualification audit, safety management system development and implementation, as well as the purchase and sale data of the report, and according to the sales record to extract a certain proportion, track and verify the flow of sales.
-
Tianmai biorecombinant human insulin intestinal capsule (ORMD-0801) started Phase III clinical
Time of Update: 2020-09-01
Recently, insight database shows that Hefei Tianmai Bio and Israel Oramed co-developed the oral insulin new drug ORMD-0801 in China to launch Phase III clinical, oral insulin from the market is a big step closer.
-
Hengrui Pharmaceuticals innovative drug SHR-A1811 was approved for clinical
Time of Update: 2020-07-31
preclinical results show that SHR-A1811 has good anti-tumor activity, safety, tolerability and pharmacokinetic characteristics, or can further improve drug resistance, improve efficacy, meet clinical needs, for the vast number of tumor patients to provide more choices.
-
Antibiotic abuse or will lead to no drug availability
Time of Update: 2020-06-30
March 6 news to participate in the national two sessions of the representative, good doctors pharmaceutical group chairman Geng Fu can told reporters that some rural areas exist in the phenomenon of
